Bixiye
QP88-19 Pharmacy Benefit Exclusion for Healthcare Professional Administered Drugs
Taariikhda uu dhaqangalayo Barnaamijka: Nov 13, 2019
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 2631 - 2640 ee natiijooyinka 3289
Bixiye
QP87-19 Medical Drug Exclusion Lists Expanded to Include Triluron – Commercial Products
Taariikhda uu dhaqangalayo Barnaamijka: Nov 13, 2019
Bixiye
QP86-19 Pharmacy Benefit Exclusion for Invermectin Cream 1%
Taariikhda uu dhaqangalayo Barnaamijka: Nov 13, 2019
Bixiye
QP90-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: tadalafil
Taariikhda uu dhaqangalayo Barnaamijka: Nov 13, 2019
Bixiye
QP89-19 CMS Provider Data Accuracy Audit
Taariikhda uu dhaqangalayo Barnaamijka: Nov 13, 2019
Bixiye
QP92-19 Multiple Claim Appeals for Minnesota Health Care Programs (MHCP)
Taariikhda uu dhaqangalayo Barnaamijka: Nov 13, 2019
Bixiye
QP91-19 Availity Provider Portal Authorization Tool Enhancements
Taariikhda uu dhaqangalayo Barnaamijka: Nov 13, 2019
Bixiye
P54R2-19 Update: Precertification for Commercial Inpatient Admissions
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2019
Bixiye
P82-19 Reimbursement Policy Clarification to Unlisted Codes for Commercial & Medicare Products
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2019
Bixiye
P80-19 2020 Renewal Changes Summary for Primary Care Clinic Providers
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2019